Page last updated: 2024-09-05

dolastatin 16 and Uterine Cervical Neoplasms

dolastatin 16 has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arendse, CE; Davies-Coleman, MT; Dzeha, TM; Gray, CA; Hendricks, DT; Hess, S; Pannell, LK1

Other Studies

1 other study(ies) available for dolastatin 16 and Uterine Cervical Neoplasms

ArticleYear
Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula.
    Journal of natural products, 2003, Volume: 66, Issue:5

    Topics: Antineoplastic Agents; Cyanobacteria; Depsipeptides; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Female; Humans; Inhibitory Concentration 50; Kenya; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2003